In this article, we will discuss Oxaprozin and Geriatric Use. So, let’s get started.
Geriatric: As with any NSAID, caution should be exercised in treating the elderly (65 years and older). No dosage adjustment is necessary in the elderly for pharmacokinetics reasons, although many
elderly may need a reduced dose due to low body weight or disorders associated with aging. A multiple dose study comparing the pharmacokinetics of oxaprozin (1200 mg QD) in 20 young (21-44 years) adults and 20 elderly (64-83 years) adults did not show any statistically significant differences between age groups.